TIMOPTIC Side Effects

5872264-9 | Trabeculectomy, Vitrectomy
on Aug 26, 2008 Female patient from UNITED KINGDOM , 29 years of age, was diagnosed with intraocular pressure increased and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: trabeculectomy, vitrectomy. Timoptic dosage: . During the same period patient was treated with APRACLONIDINE (View Apraclonidine Review and Apraclonidine Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).

5866184-3 | Diplopia, Eyelid Disorder, Hydrocephalus, Ophthalmoplegia
Patient was taking Timoptic (View Usage). Patient had the following side effects: diplopia, eyelid disorder, hydrocephalus (What is hydrocephalus?), ophthalmoplegia on Aug 13, 2008 from BRAZIL Additional patient health information: Female patient , 53 years of age, weighting 112.4 lb, was diagnosed with intraocular pressure test, blood pressure increased, diabetes mellitus and. Timoptic dosage: . During the same period patient was treated with AMLODIPINE BESYLATE AND ENALAPRIL MALEATE (View Amlodipine Besylate And Enalapril Maleate Review and Amlodipine Besylate And Enalapril Maleate Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

5859816-7 | Adverse Event, Cardiac Disorder, Cardiac Failure Congestive, Chest Pain, Fatigue
Adverse event was reported on Aug 18, 2008 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with eye injury, glaucoma (What is glaucoma?) and. Location: UNITED STATES , 74 years of age, weighting 185.2 lb, After Timoptic was administered, patient had the following side effects: adverse event, cardiac disorder, cardiac failure congestive, chest pain (What is chest pain?), fatigue. During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ).

5859785-X | Corneal Epithelium Defect
on Aug 21, 2008 Female patient from UNITED KINGDOM , 83 years of age, was diagnosed with ulcerative keratitis and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: corneal epithelium defect. Timoptic dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ).


5858866-4 | Corneal Epithelium Defect
on Aug 19, 2008 Female patient from UNITED KINGDOM , 64 years of age, was diagnosed with corneal graft rejection, endothelial dysfunction and was treated with Timoptic (View Usage). Patient had the following side effects: corneal epithelium defect. Timoptic dosage: . During the same period patient was treated with OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5858864-0 | Diplopia, Eyelid Disorder, Hydrocephalus, Ophthalmoplegia
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: diplopia, eyelid disorder, hydrocephalus (What is hydrocephalus?), ophthalmoplegia on Aug 13, 2008 from BRAZIL Additional patient health information: Female patient , 53 years of age, weighting 112.4 lb, was diagnosed with intraocular pressure test, blood pressure increased, diabetes mellitus and. Timoptic dosage: . During the same period patient was treated with AMLODIPINE BESYLATE AND ENALAPRIL MALEATE (View Amlodipine Besylate And Enalapril Maleate Review and Amlodipine Besylate And Enalapril Maleate Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

5847425-5 | Iris Adhesions, Vitreous Haemorrhage
Adverse event was reported on Jul 23, 2008 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED KINGDOM , 20 years of age, Patient experienced the following unwanted or unexpected effects: iris adhesions, vitreous haemorrhage. During the same period patient was treated with BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), INSULIN (View Insulin Review and Insulin Label ).

5841002-8 | Iris Adhesions, Vitreous Haemorrhage
on Aug 05, 2008 Female patient from UNITED KINGDOM , 20 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient had the following side effects: iris adhesions, vitreous haemorrhage. Timoptic dosage: . During the same period patient was treated with BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), INSULIN (View Insulin Review and Insulin Label ).

5834030-X | Iris Adhesions, Retinal Tear, Vitreous Haemorrhage
on Jul 23, 2008 Female patient from UNITED KINGDOM , 20 years of age, was diagnosed with intraocular pressure increased and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: iris adhesions, retinal tear, vitreous haemorrhage. Timoptic dosage: . During the same period patient was treated with BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), INSULIN (View Insulin Review and Insulin Label ).

5831526-1 | Blood Pressure Increased, Blood Thyroid Stimulating Hormone Increased, Chest Pain, Dyspnoea Exertional, Hypothyroidism, Retinal Vein Thrombosis, Sinus Bradycardia
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, blood thyroid stimulating hormone increased, chest pain (What is chest pain?), dyspnoea exertional, hypothyroidism, retinal vein thrombosis, sinus bradycardia on Jul 21, 2008 from UNITED STATES Additional patient health information: Female patient , 76 years of age, . Timoptic dosage: . During the same period patient was treated with COMBIGAN (View Combigan Review and Combigan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5825752-5 | Corneal Epithelium Defect
Adverse event was reported on Jul 24, 2008 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with ulcerative keratitis and. Location: UNITED KINGDOM , 83 years of age, Patient had the following side effects: corneal epithelium defect. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ).

5821985-2 | Dizziness, Feeling Abnormal, Glaucoma, Heart Rate Decreased, Palpitations
on Jul 22, 2008 Female patient from UNITED STATES , 90 years of age, weighting 141.1 lb, was diagnosed with glaucoma (What is glaucoma?), back pain (What is back pain?), arthritis (What is arthritis?), blood pressure (What is blood pressure?) and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: dizziness (What is dizziness?), feeling abnormal, glaucoma (What is glaucoma?), heart rate decreased, palpitations. Timoptic dosage: . During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), PILOCARPINE (View Pilocarpine Review and Pilocarpine Label ), CELEBREX (View Celebrex Review and Celebrex Label ), VASOTEC (View Vasotec Review and Vasotec Label ).

5805170-6 | Device Malfunction, Eye Disorder, Eye Irritation, Lacrimation Increased, Ocular Hyperaemia, Vision Blurred
on Jul 07, 2008 Male patient from UNITED STATES , 68 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: device malfunction, eye disorder, eye irritation, lacrimation increased, ocular hyperaemia, vision blurred. Timoptic dosage: . During the same period patient was treated with ALPHAGAN (View Alphagan Review and Alphagan Label ), LUMIGAN (View Lumigan Review and Lumigan Label ), NORVASC (View Norvasc Review and Norvasc Label ), PEPCID (View Pepcid Review and Pepcid Label ), GLUCOPHAGE XR (View Glucophage Xr Review and Glucophage Xr Label ), ATACAND (View Atacand Review and Atacand Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), COLCHICINE (View Colchicine Review and Colchicine Label ).

5805163-9 | Iris Adhesions, Vitreous Haemorrhage
Patient was taking Timoptic (View Usage). Patient had the following side effects: iris adhesions, vitreous haemorrhage on Jun 30, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 20 years of age, was diagnosed with intraocular pressure increased and. Timoptic dosage: . During the same period patient was treated with BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), INSULIN (View Insulin Review and Insulin Label ).

5794685-5 | Trabeculectomy, Vitrectomy
Adverse event was reported on Jun 16, 2008 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with intraocular pressure increased and. Location: UNITED KINGDOM , 29 years of age, After Timoptic was administered, patient had the following side effects: trabeculectomy, vitrectomy. During the same period patient was treated with APRACLONIDINE (View Apraclonidine Review and Apraclonidine Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).

5792501-9 | Atrioventricular Block
on Jun 19, 2008 Female patient from SPAIN , 74 years of age, was diagnosed with glaucoma (What is glaucoma?), hypertension, bronchitis (What is bronchitis?) and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block. Timoptic dosage: . During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (View Bisoprolol Fumarate And Hydrochlorothiazide Review and Bisoprolol Fumarate And Hydrochlorothiazide Label ), ACETYLCYSTEINE AND THIAMPHENICOL (View Acetylcysteine And Thiamphenicol Review and Acetylcysteine And Thiamphenicol Label ), HYDROCHLOROTHIAZIDE AND TELMISARTAN (View Hydrochlorothiazide And Telmisartan Review and Hydrochlorothiazide And Telmisartan Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ). Patient was hospitalized.

5792497-X | Iris Adhesions, Vitreous Haemorrhage
on Jun 18, 2008 Female patient from UNITED KINGDOM , 20 years of age, was diagnosed with intraocular pressure increased and was treated with Timoptic (View Usage). Patient had the following side effects: iris adhesions, vitreous haemorrhage. Timoptic dosage: . During the same period patient was treated with BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).

5780968-1 | Bone Disorder, Fatigue, Intraocular Pressure Increased
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: bone disorder, fatigue, intraocular pressure increased on Jun 16, 2008 from AUSTRALIA Additional patient health information: Female patient , 69 years of age, was diagnosed with intraocular pressure increased and. Timoptic dosage: .

5776023-7 | Corneal Deposits
Adverse event was reported on Jun 06, 2008 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with keratitis, keratitis herpetic and. Location: UNITED KINGDOM , 89 years of age, Patient experienced the following unwanted or unexpected effects: corneal deposits. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5768201-8 | Corneal Deposits
on Jun 09, 2008 Male patient from UNITED KINGDOM , 46 years of age, was diagnosed with corneal epithelium defect and was treated with Timoptic (View Usage). Patient had the following side effects: corneal deposits. Timoptic dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ).

5759265-6 | Corneal Epithelium Defect
on Jun 02, 2008 Female patient from UNITED KINGDOM , 64 years of age, was diagnosed with corneal graft rejection, endothelial dysfunction and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: corneal epithelium defect. Timoptic dosage: . During the same period patient was treated with OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5752968-9 | Corneal Deposits
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: corneal deposits on May 27, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 46 years of age, was diagnosed with corneal epithelium defect and. Timoptic dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ).

5750924-8 | Corneal Epithelium Defect
Adverse event was reported on May 22, 2008 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with corneal graft rejection, endothelial dysfunction and. Location: UNITED KINGDOM , 64 years of age, Patient had the following side effects: corneal epithelium defect. During the same period patient was treated with OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5750919-4 | Corneal Epithelium Defect
on May 22, 2008 Female patient from UNITED KINGDOM , 83 years of age, was diagnosed with ulcerative keratitis and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: corneal epithelium defect. Timoptic dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ).

5744267-6 | Device Malfunction, Eye Disorder, Eye Irritation, Vision Blurred
on May 13, 2008 Male patient from UNITED STATES , 68 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: device malfunction, eye disorder, eye irritation, vision blurred. Timoptic dosage: . During the same period patient was treated with ALPHAGAN (View Alphagan Review and Alphagan Label ), LUMIGAN (View Lumigan Review and Lumigan Label ), NORVASC (View Norvasc Review and Norvasc Label ), PEPCID (View Pepcid Review and Pepcid Label ), GLUCOPHAGE XR (View Glucophage Xr Review and Glucophage Xr Label ), ATACAND (View Atacand Review and Atacand Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), COLCHICINE (View Colchicine Review and Colchicine Label ).

5719820-6 | Dyskinesia, Fear, Feeling Abnormal, Muscle Tightness, Nervousness, Paraesthesia, Pruritus
Patient was taking Timoptic (View Usage). Patient had the following side effects: dyskinesia, fear, feeling abnormal, muscle tightness, nervousness, paraesthesia, pruritus on Apr 18, 2008 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 180.8 lb, was diagnosed with glaucoma (What is glaucoma?) and. Timoptic dosage: . During the same period patient was treated with LUMIGAN (View Lumigan Review and Lumigan Label ), TIMOPTIC XE (View Timoptic-xe Review and Timoptic-xe Label ). Patient was hospitalized.

5693676-2 | Bradycardia, Loss Of Consciousness
Adverse event was reported on Mar 21, 2008 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with ocular hypertension and. Location: JAPAN , 64 years of age, weighting 165.3 lb, After Timoptic was administered, patient had the following side effects: bradycardia, loss of consciousness. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), AMLODIN (View Amlodin Review and Amlodin Label ). Patient was hospitalized.

5688729-9 | Bradycardia, Loss Of Consciousness
on Mar 21, 2008 Male patient from JAPAN , 64 years of age, weighting 165.3 lb, was diagnosed with ocular hypertension and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, loss of consciousness. Timoptic dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), AMLODIN (View Amlodin Review and Amlodin Label ). Patient was hospitalized.

5627875-2 | Keratopathy
on Feb 12, 2008 Female patient from UNITED KINGDOM , 43 years of age, weighting 130.1 lb, was diagnosed with glaucoma (What is glaucoma?), surgery (What is surgery?), dry eye and was treated with Timoptic (View Usage). Patient had the following side effects: keratopathy. Timoptic dosage: . During the same period patient was treated with BETAMETHASONE SODIUM PHOSPHATE (View Betamethasone Sodium Phosphate Review and Betamethasone Sodium Phosphate Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ), CARBOXYMETHYLCELLULOSE SODIUM (View Carboxymethylcellulose Sodium Review and Carboxymethylcellulose Sodium Label ). Patient was hospitalized and became disabled.

5590653-7 | Corneal Decompensation, Intraocular Pressure Increased, Uveitis
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: corneal decompensation, intraocular pressure increased, uveitis on Jan 08, 2008 from IRAN (ISLAMIC REPUBLIC OF) Additional patient health information: Male patient , 25 years of age, was diagnosed with photophobia, intraocular pressure increased and. Timoptic dosage: . During the same period patient was treated with TRUSOPT (View Trusopt Review and Trusopt Label ).

5590638-0 | Blepharitis, Retinal Detachment
Adverse event was reported on Jan 03, 2008 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: SPAIN , 60 years of age, Patient experienced the following unwanted or unexpected effects: blepharitis, retinal detachment. During the same period patient was treated with BRIMONIDINE TARTRATE AND TIMOLOL MALEATE (View Brimonidine Tartrate And Timolol Maleate Review and Brimonidine Tartrate And Timolol Maleate Label ), TRAVOPROST (View Travoprost Review and Travoprost Label ).

5587588-2 | Abdominal Pain, Dyspepsia, Myalgia, Nocturia, Pain In Extremity, Sleep Disorder
on Jan 08, 2008 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with ocular hypertension and was treated with Timoptic (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), dyspepsia, myalgia, nocturia, pain in extremity, sleep disorder (What is sleep disorder?). Timoptic dosage: . During the same period patient was treated with AZOPT (View Azopt Review and Azopt Label ), TRAVATAN (View Travatan Review and Travatan Label ), XALATAN (View Xalatan Review and Xalatan Label ).

5575541-4 | Dyskinesia, Nervousness, Paraesthesia, Pruritus
on Dec 12, 2007 Male patient from UNITED STATES , 60 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: dyskinesia, nervousness, paraesthesia, pruritus. Timoptic dosage: . During the same period patient was treated with LUMIGAN (View Lumigan Review and Lumigan Label ). Patient was hospitalized.

5556130-4 | Eye Burns, Eye Pain, Intraocular Pressure Increased
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: eye burns, eye pain, intraocular pressure increased on Dec 11, 2007 from CANADA Additional patient health information: Female patient , 73 years of age, weighting 119.0 lb, . Timoptic dosage: . During the same period patient was treated with BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).

5507805-4 | Dizziness, Heart Rate Decreased, Myocardial Infarction, Overdose
Adverse event was reported on Oct 26, 2007 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , 52 years of age, Patient had the following side effects: dizziness (What is dizziness?), heart rate decreased, myocardial infarction, overdose. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ).

5505875-0 | Acrochordon, Basal Cell Carcinoma
on Oct 30, 2007 Male patient from UNITED KINGDOM , 47 years of age, was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: acrochordon, basal cell carcinoma. Timoptic dosage: . During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ).

5501279-5 | Flat Anterior Chamber Of Eye, Intraocular Pressure Increased
on Oct 23, 2007 Female patient from UNITED STATES , 48 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: flat anterior chamber of eye, intraocular pressure increased. Timoptic dosage: .

5500951-0 | Atrioventricular Block First Degree, Cardiac Failure, Cardiomegaly, Dyspnoea, Ischaemia, Oedema Peripheral, Pulmonary Oedema
Patient was taking Timoptic (View Usage). Patient had the following side effects: atrioventricular block first degree, cardiac failure, cardiomegaly, dyspnoea, ischaemia, oedema peripheral, pulmonary oedema on Oct 27, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 75 years of age, weighting 212.7 lb, was diagnosed with glaucoma (What is glaucoma?), hypertension and. Timoptic dosage: . During the same period patient was treated with LOSARTAN POTASSIUM (100 Mg / Day) (View Losartan Potassium Review and Losartan Potassium Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), HUMAN INSULATARD (View Human Insulatard Review and Human Insulatard Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ). Patient was hospitalized.

5493920-0 | Dyspnoea, Hyperventilation
Adverse event was reported on Oct 18, 2007 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?), diabetes mellitus, hypertension and. Location: UNITED KINGDOM , 82 years of age, weighting 282.2 lb, After Timoptic was administered, patient had the following side effects: dyspnoea, hyperventilation. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), XALATAN (View Xalatan Review and Xalatan Label ), BIMATOPROST (View Bimatoprost Review and Bimatoprost Label ).

5488797-3 | Dyspnoea, Hyperventilation
on Oct 12, 2007 Female patient from UNITED KINGDOM , 82 years of age, weighting 282.2 lb, was diagnosed with glaucoma (What is glaucoma?), diabetes mellitus, hypertension and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, hyperventilation. Timoptic dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), XALATAN (View Xalatan Review and Xalatan Label ), BIMATOPROST (View Bimatoprost Review and Bimatoprost Label ).

5463240-9 | Blepharitis, Conjunctival Hyperaemia, Disorientation, Visual Field Defect
on Sep 14, 2007 Female patient from UNITED KINGDOM , 77 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient had the following side effects: blepharitis, conjunctival hyperaemia, disorientation, visual field defect. Timoptic dosage: . During the same period patient was treated with BIMATOPROST (View Bimatoprost Review and Bimatoprost Label ), BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ). Patient was hospitalized.

5460734-7 | Presyncope, Therapeutic Response Unexpected, Wheezing
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: presyncope, therapeutic response unexpected, wheezing on Sep 17, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 85 years of age, was diagnosed with glaucoma (What is glaucoma?), cardiac failure congestive, osteoporosis (What is osteoporosis?), hypercholesterolaemia and. Timoptic dosage: . During the same period patient was treated with BETAXOLOL HYDROCHLORIDE (View Betaxolol Hydrochloride Review and Betaxolol Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), CIPROFIBRATE (View Ciprofibrate Review and Ciprofibrate Label ).

5445635-2 | Blepharitis, Conjunctival Hyperaemia, Disorientation, Visual Field Defect
Adverse event was reported on Sep 03, 2007 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED KINGDOM , 77 years of age, Patient experienced the following unwanted or unexpected effects: blepharitis, conjunctival hyperaemia, disorientation, visual field defect. During the same period patient was treated with BIMATOPROST (View Bimatoprost Review and Bimatoprost Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ). Patient was hospitalized.

5432190-6 | Blepharitis, Conjunctival Hyperaemia, Disorientation, Visual Field Defect
on Aug 24, 2007 Female patient from UNITED KINGDOM , 77 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient had the following side effects: blepharitis, conjunctival hyperaemia, disorientation, visual field defect. Timoptic dosage: . During the same period patient was treated with BIMATOPROST (View Bimatoprost Review and Bimatoprost Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ). Patient was hospitalized.

5386665-9 | Choroidal Detachment, Hypotony Of Eye
on Jul 02, 2007 Female patient from SPAIN , 40 years of age, was diagnosed with ocular hypertension and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: choroidal detachment, hypotony of eye. Timoptic dosage: .

5386656-8 | Choroidal Detachment, Hypotony Of Eye, Maculopathy
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: choroidal detachment, hypotony of eye, maculopathy on Jul 02, 2007 from SPAIN Additional patient health information: Female patient , 68 years of age, was diagnosed with ocular hypertension and. Timoptic dosage: .

5382388-0 | Gynaecomastia
Adverse event was reported on Jun 27, 2007 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?), proctocolitis, peptic ulcer haemorrhage, prophylaxis, spondyloarthropathy, essential hypertension, bone disorder and. Location: SPAIN , 36 years of age, weighting 178.6 lb, Patient had the following side effects: gynaecomastia. During the same period patient was treated with DACORTIN (View Dacortin Review and Dacortin Label ), PARIET (View Pariet Review and Pariet Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), ATACAND (View Atacand Review and Atacand Label ), TRAVATAN (View Travatan Review and Travatan Label ), CLAVERSAL (View Claversal Review and Claversal Label ), ACTONEL (View Actonel Review and Actonel Label ).

5381936-4 | Gynaecomastia
on Jun 27, 2007 Male patient from SPAIN , 36 years of age, weighting 178.6 lb, was diagnosed with glaucoma (What is glaucoma?), proctocolitis, peptic ulcer haemorrhage, prophylaxis, spondyloarthropathy, essential hypertension, bone disorder and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: gynaecomastia. Timoptic dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), TRAVOPROST (View Travoprost Review and Travoprost Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label ).

5359496-3 | Blepharoplasty, Conjunctival Oedema, Dermatitis, Ectropion, Erythema, Periorbital Oedema, Skin Exfoliation
on Jun 01, 2007 Male patient from UNITED KINGDOM , 76 years of age, was diagnosed with open angle glaucoma and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation. Timoptic dosage: . During the same period patient was treated with ALPHAGAN (View Alphagan Review and Alphagan Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

5359495-1 | Blepharoplasty, Conjunctival Oedema, Dermatitis, Ectropion, Erythema, Periorbital Oedema, Skin Exfoliation
Patient was taking Timoptic (View Usage). Patient had the following side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation on Mar 19, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 76 years of age, was diagnosed with open angle glaucoma and. Timoptic dosage: . During the same period patient was treated with BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), DORZOLAMIDE HYDROCHLORIDE (View Dorzolamide Hydrochloride Review and Dorzolamide Hydrochloride Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ). Patient was hospitalized.